Immuneering Corp revenue

Immuneering Corp's revenue was $0 in fiscal 2023, down 100.0% on the year before.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Immuneering Corp: revenue history, annual
Fiscal year	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023
Revenue	2,312	2,080	317	0
Growth on the year before	—	−10.0%	−84.8%	−100.0%
Gross profit	1,031	927	159	0
Gross margin	44.6%	44.6%	50.1%	—

US$ thousands unless shown otherwise. Fiscal quarters.

Immuneering Corp: revenue history, quarterly
Quarter	2022 Q1Mar 2022	2022 Q2Jun 2022	2022 Q3Sept 2022	2022 Q4Dec 2022	2023 Q1Mar 2023	2023 Q2Jun 2023	2023 Q3Sept 2023	2023 Q4Dec 2023
Revenue	184	94	38	0	0	0	0	0
Growth on the same quarter a year before	—	—	—	—	−100.0%	−100.0%	−100.0%	−100.0%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Immuneering Corp's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Immuneering Corp.